GGrantIndex
← Leaderboards

Henry Jerrold Kaplan

Washington University

$5,921,998
Attributed
$7,124,371
Total exposure
9
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $719.9K · FY200518
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$7,124,371 · 9

By mechanism

R01$3,858,620 · 3
R24$1,035,682 · 1
R42$977,329 · 1
R21$833,633 · 2
R41$342,741 · 1
T35$76,366 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Vision

Research focus

VisionBaseBlindnessCellsLaboratory RatAutoimmune DisorderLeadVisualLifeAreaBioimaging /Biomedical ImagingImageUveitisStagingAdultProgramsAntigen Presenting CellExudative Age-Related Macular DegenerationGeneticCell AdhesionAge Related Macular DegenerationEndothelial CellsBlood VesselsB Lymphocyte

Grant awards (25)

Summer Vision Sciences Training Program$38,507
T35 · FY2018 · EY
Cone Rescue in Retinitis Pigmentosa$588,677
R01 · FY2017 · EY · contact PI
Summer Vision Sciences Training Program$37,859
T35 · FY2017 · EY
Cone Rescue in Retinitis Pigmentosa$532,383
R01 · FY2016 · EY · contact PI
Exsomes derived from retinal astrocytes in the regulation of retinal vasculature$187,500
R21 · FY2016 · EY
Exsomes derived from retinal astrocytes in the regulation of retinal vasculature$225,000
R21 · FY2015 · EY
P23H Rhodopsin Mutant Swine Model of Reninitis Pigmentosa$185,943
R21 · FY2012 · EY · contact PI
P23H Rhodopsin Mutant Swine Model of Reninitis Pigmentosa$235,190
R21 · FY2011 · EY · contact PI
Targeting drug delivery nanoparticles to sites of inflammation$391,672
R42 · FY2009 · EY · contact PI
Targeting drug delivery nanoparticles to sites of inflammation$297,995
R42 · FY2009 · EY · contact PI
Targeting drug delivery nanoparticles to sites of inflammation$287,662
R42 · FY2008 · EY · contact PI
Vision Research Infrastructure Development$186,659
R24 · FY2008 · EY · contact PI
Vision Research Infrastructure Development$183,807
R24 · FY2007 · EY · contact PI
Targeting drug-delivery nanoparticles to sites of inflammation$342,741
R41 · FY2006 · EY · contact PI
Vision Research Infrastructure Development$180,570
R24 · FY2006 · EY · contact PI
Vision Research Infrastructure Development$177,973
R24 · FY2005 · EY
Vision Research Infrastructure Development$306,673
R24 · FY2004 · EY
IN VIVO IMAGING IN AUTOIMMUNE UVEITIS$545,998
R01 · FY2003 · EY
IN VIVO IMAGING IN AUTOIMMUNE UVEITIS$545,998
R01 · FY2002 · EY
IN VIVO IMAGING IN AUTOIMMUNE UVEITIS$545,998
R01 · FY2001 · EY
EAAU--ANTIGEN STRUCTURE AND THERAPY$265,191
R01 · FY2001 · EY
IN VIVO IMAGING IN AUTOIMMUNE UVEITIS$331,771
R01 · FY2000 · EY
IN VIVO IMAGING IN AUTOIMMUNE UVEITIS$214,227
R01 · FY2000 · EY
EAAU--ANTIGEN STRUCTURE AND THERAPY$195,677
R01 · FY2000 · EY
EAAU--ANTIGEN STRUCTURE AND THERAPY$92,700
R01 · FY2000 · EY